1. Home
  2. CX vs QGEN Comparison

CX vs QGEN Comparison

Compare CX & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemex S.A.B. de C.V. Sponsored ADR

CX

Cemex S.A.B. de C.V. Sponsored ADR

N/A

Current Price

$9.91

Market Cap

14.7B

Sector

Industrials

ML Signal

N/A

QGEN

Qiagen N.V.

N/A

Current Price

$49.55

Market Cap

9.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CX
QGEN
Founded
1906
1986
Country
Mexico
Netherlands
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.7B
9.0B
IPO Year
2000
1998

Fundamental Metrics

Financial Performance
Metric
CX
QGEN
Price
$9.91
$49.55
Analyst Decision
Buy
Hold
Analyst Count
15
12
Target Price
$14.77
★ $49.77
AVG Volume (30 Days)
★ 7.1M
5.9M
Earning Date
10-26-2026
11-04-2026
Dividend Yield
1.06%
★ 5.55%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.02
$2.21
Revenue Next Year
$3.39
$5.11
P/E Ratio
★ $19.03
$24.01
Revenue Growth
N/A
N/A
52 Week Low
$9.30
$32.53
52 Week High
$13.67
$57.82

Technical Indicators

Market Signals
Indicator
CX
QGEN
Relative Strength Index (RSI) 39.79 55.87
Support Level $9.30 $47.37
Resistance Level $10.05 $49.86
Average True Range (ATR) 0.30 0.24
MACD -0.10 -0.33
Stochastic Oscillator 0.98 1.04

Price Performance

Historical Comparison
CX
QGEN

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).

Share on Social Networks: